Unlocking the Future of Liquid Biopsy Research

Tuesday, July 25
10:30 – 10:50 a.m.
Exhibit Hall Theater 2
Supported by BioIVT


Liquid biopsy research is a promising field of study that can potentially revolutionize the way we detect, diagnose, and treat diseases. Access to relevant specimens is an essential part of any discovery and development research program, but the complexity and cost associated with procuring these samples can be daunting. While no universal standard for liquid biopsy bio-banking exists, there are known collection conditions that can influence analytical variability and reduce the risk of failure rates. Further, validation of molecular biomarkers requires access to a heterogeneous cohort of disease state and control donor to support clinical utility. To unlock the full potential of liquid biopsy research, it is important to have standardized collection protocols and a diverse donor base to develop more accurate models that will translate to better decisions in healthcare.


Courtney Noah
VP, Scientific Affairs, BioIVT